chr1-155247900-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_006589.3(ENTREP3):​c.1889G>T​(p.Cys630Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000271 in 1,583,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

ENTREP3
NM_006589.3 missense

Scores

1
9
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.52

Publications

1 publications found
Variant links:
Genes affected
ENTREP3 (HGNC:1233): (endosomal transmembrane epsin interactor 3) This gene is located near the gene for the lysosomal enzyme glucosylceramidase; a deficiency in this enzyme is associated with Gaucher disease. The encoded protein has been identified as a potential binding partner of a WW domain-containing protein which is involved in apoptosis and tumor suppression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.41614512).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENTREP3NM_006589.3 linkc.1889G>T p.Cys630Phe missense_variant Exon 12 of 12 ENST00000361361.7 NP_006580.2 P81408-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENTREP3ENST00000361361.7 linkc.1889G>T p.Cys630Phe missense_variant Exon 12 of 12 1 NM_006589.3 ENSP00000354958.2 P81408-1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152244
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000514
AC:
11
AN:
214150
AF XY:
0.0000603
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000335
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000937
Gnomad OTH exome
AF:
0.000192
GnomAD4 exome
AF:
0.0000251
AC:
36
AN:
1431728
Hom.:
0
Cov.:
33
AF XY:
0.0000394
AC XY:
28
AN XY:
709854
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32474
American (AMR)
AF:
0.0000502
AC:
2
AN:
39862
Ashkenazi Jewish (ASJ)
AF:
0.0000412
AC:
1
AN:
24282
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39314
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81524
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51938
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5642
European-Non Finnish (NFE)
AF:
0.0000282
AC:
31
AN:
1097732
Other (OTH)
AF:
0.0000339
AC:
2
AN:
58960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152244
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41466
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68044
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 22, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1889G>T (p.C630F) alteration is located in exon 12 (coding exon 12) of the FAM189B gene. This alteration results from a G to T substitution at nucleotide position 1889, causing the cysteine (C) at amino acid position 630 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.88
BayesDel_addAF
Uncertain
0.017
T
BayesDel_noAF
Uncertain
-0.010
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.25
.;.;T
Eigen
Benign
0.15
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.94
D
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.42
T;T;T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
1.1
.;.;L
PhyloP100
4.5
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-3.7
D;D;D
REVEL
Benign
0.21
Sift
Uncertain
0.0010
D;D;D
Sift4G
Uncertain
0.0020
D;D;D
Polyphen
0.51
P;.;B
Vest4
0.68
MutPred
0.47
.;.;Gain of MoRF binding (P = 0.0707);
MVP
0.27
MPC
0.21
ClinPred
0.69
D
GERP RS
4.5
Varity_R
0.71
gMVP
0.52
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs750576160; hg19: chr1-155217691; API